Terns Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
(inaudible) morning, and welcome to the Jefferies Global Healthcare Conference. My name is Mia Moss with the Jefferies Investment Banking team. And it's my great pleasure to introduce Erin Quirk, President, Head of R&D at Terns Pharma. Thank you.
Thanks so much for that introduction, Mia, and thanks to the entire Jefferies team for the opportunity to be here today and present Terns Pharmaceuticals. So as always, I'd invite you to take a look at our forward-looking statements, which are listed in full on our website.
So Terns is a publicly traded pharmaceutical company based in San Francisco. We're developing small molecule medicines with clinically validated mechanisms of action to address important and serious diseases, including oncology and metabolic diseases with high unmet need. We have discovered three assets internally in three different classes with validated mechanisms, where we think the molecules that we have discovered
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |